VNUS Closure Catheter System Cleared For Venous Insufficiency Treatment
This article was originally published in The Gray Sheet
Executive Summary
VNUS Medical Technologies plans to begin shipment of its Closure system March 26, following FDA's March 17 510(k) clearance of device for the endovascular coagulation of blood vessels in patients with superficial vein reflux, the company announced in a March 22 release.
You may also be interested in...
Vnus To Double Closure Sales Force Following $57.5 Mil. IPO
Vnus Medical Technologies intends to spend at least $8 mil. of the proceeds from a proposed $57.5 mil. initial public offering on sales, marketing and reimbursement activities, the company disclosed in an Aug. 18 prospectus outlining the deal.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.